Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Pranav Shah, Priya Dubey, Bhavin Vyas, Ankur Kaul, Anil Kumar Mishra, Dimple Chopra & Priya Patel. (2021) Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study. Artificial Cells, Nanomedicine, and Biotechnology 49:1, pages 511-522.
Read now
Read now
Piyong Sola, Praveen Krishnamurthy, Pavan Kumar Chintamaneni, Sai Kiran S.S Pindiprolu & Mamta Kumari. (2020) Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opinion on Drug Delivery 17:8, pages 1119-1132.
Read now
Read now
Saleha Rehman, Bushra Nabi, Ameeduzzafar Zafar, Sanjula Baboota & Javed Ali. (2019) Intranasal delivery of mucoadhesive nanocarriers: a viable option for Parkinson’s disease treatment?. Expert Opinion on Drug Delivery 16:12, pages 1355-1366.
Read now
Read now
Suresh Palle & Prasad Neerati. (2018) Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats. Xenobiotica 48:10, pages 1028-1036.
Read now
Read now
Viney Lather, Dharmpal Sharma & Deepti Pandita. (2016) Proniosomal gel-mediated transdermal delivery of bromocriptine: in vitro and ex vivo evaluation. Journal of Experimental Nanoscience 11:13, pages 1044-1057.
Read now
Read now
Abhijeet D. Kulkarni, Yogesh H. Vanjari, Karan H. Sancheti, Veena S. Belgamwar, Sanjay J. Surana & Chandrakantsing V. Pardeshi. (2015) Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini review. Journal of Drug Targeting 23:9, pages 775-788.
Read now
Read now
Gulam Mustafa, Alka Ahuja, Abdulmohsen H Al Rohaimi, Shahnawaz Muslim, Allam A Hassan, Sanjula Baboota & Javed Ali. (2015) Nano-ropinirole for the management of Parkinsonism: blood–brain pharmacokinetics and carrier localization. Expert Review of Neurotherapeutics 15:6, pages 695-710.
Read now
Read now
Articles from other publishers (58)
Someshbabu Ramesh Babu, Harshith Hosahalli Shekara, Ashish Kumar Sahoo, Pyda Venkata Harsha Vardhan, Nitheesh Thiruppathi & Madhugiri Prakash Venkatesh. (2023) Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review. Therapeutic Delivery 14:9, pages 571-594.
Crossref
Crossref
Shobhit Kumar, Satish Kumar Gupta & Rakesh Pahwa. (2023) Designing lisuride intranasal nanocarrier system for reduction of oxidative damage with enhanced dopamine level in brain for Parkinsonism. Journal of Psychiatric Research 165, pages 205-218.
Crossref
Crossref
Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova & Jianqin Lu. (2023) Nanotechnology‐empowered therapeutics targeting neurodegenerative diseases. WIREs Nanomedicine and Nanobiotechnology 15:5.
Crossref
Crossref
Youssef Ait Hamdan, Samia Elouali, Abdelali Ben Maloui, Bilal El-Mansoury, Hassane Oudadesse & Mohammed Rhazi. 2023. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease. Experimental and Clinical Evidence of the Neuropathology of Parkinson’s Disease
253
274
.
Paramita Saha, Himanshu Kathuria & Murali Monohar Pandey. (2023) Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease. Journal of Controlled Release 358, pages 293-318.
Crossref
Crossref
Vanshita Singh, Akash Garg, Rajeev Sharma & Hitesh Kumar Dewangan. (2023) Recent Advances of Nanotechnology in Brain Targeting. Current Nanoscience 19:3, pages 350-361.
Crossref
Crossref
Paramita Saha, Prabhjeet Singh, Himanshu Kathuria, Deepak Chitkara & Murali Monohar Pandey. (2023) Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency. Pharmaceutics 15:3, pages 851.
Crossref
Crossref
Paramita Saha, Himanshu Kathuria & Murali Monohar Pandey. (2023) Nose-to-brain delivery of rotigotine redispersible nanosuspension: In vitro and in vivo characterization. Journal of Drug Delivery Science and Technology 79, pages 104049.
Crossref
Crossref
Li Du, Lin Chen, Fangfang Liu, Wenya Wang & Hongyun Huang. 2023. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors. Nanowired Delivery of Drugs and Antibodies for Neuroprotection in Brain Diseases with Co-morbidity Factors
255
297
.
Deepshi Arora, Shailendra Bhatt, Manish Kumar, Rupesh K. Gautam, Yugam Taneja & Muskan Chauhan. 2023. Recent Advances in Pharmaceutical Innovation and Research. Recent Advances in Pharmaceutical Innovation and Research
447
477
.
Madeleine S. A. Tan, Preeti Pandey, Rink-Jan Lohman, James R. Falconer, Dan J. Siskind & Harendra S. Parekh. (2022) Fabrication and Characterization of Clozapine Nanoemulsion Sol–Gel for Intranasal Administration. Molecular Pharmaceutics 19:11, pages 4055-4066.
Crossref
Crossref
Bakr Ahmed, Md Rizwanullah, Showkat Rasool Mir, M Shaheer Akhtar & Saima Amin. (2022) Development of cannabidiol nanoemulsion for direct nose to brain delivery: statistical optimization, in vitro and in vivo evaluation. Biomedical Materials 17:6, pages 065009.
Crossref
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Crossref
Yong-Bo Zhang, Dong Xu, Lu Bai, Yan-Ming Zhou, Han Zhang & Yuan-Lu Cui. (2022) A Review of Non-Invasive Drug Delivery through Respiratory Routes. Pharmaceutics 14:9, pages 1974.
Crossref
Crossref
Faiza Naz, Abdul Malik, Muhammad Riaz, Qaisar Mahmood, Malik Hassan Mehmood, Ghulam Rasool, Zahed Mahmood & Mazhar Abbas. (2022) Bromocriptine therapy: Review of mechanism of action, safety and tolerability. Clinical and Experimental Pharmacology and Physiology 49:8, pages 903-922.
Crossref
Crossref
Muhammad Usama Ashhar, Preeti Vyas, Divya Vohora, Pravat Kumar Sahoo, Kuldeep Nigam, Shweta Dang, Javed Ali & Sanjula Baboota. (2022) Amelioration of oxidative stress utilizing nanoemulsion loaded with bromocriptine and glutathione for the management of Parkinson's disease. International Journal of Pharmaceutics 618, pages 121683.
Crossref
Crossref
Harshvardhan Jain, Bala Prabhakar & Pravin Shende. (2022) Modulation of olfactory area for effective transportation of actives in CNS disorders. Journal of Drug Delivery Science and Technology 68, pages 103091.
Crossref
Crossref
Chhavi Bhalothia & Girima Nagda. (2022) Nanotherapeutics a promising approach for treatment of Parkinson’s disease. Materials Today: Proceedings 69, pages A1-A13.
Crossref
Crossref
Javed Ahmad, Nafis Haider, Mohammad Ahmed Khan, Shadab Md, Nabil A. Alhakamy, Mohammed M. Ghoneim, Sultan Alshehri, Syed Sarim Imam, Mohammad Zaki Ahmad & Awanish Mishra. (2022) Novel therapeutic interventions for combating Parkinson’s disease and prospects of Nose-to-Brain drug delivery. Biochemical Pharmacology 195, pages 114849.
Crossref
Crossref
Jyotsna Shankar, Geetha K.M & Barnabas Wilson. (2021) Potential applications of nanomedicine for treating Parkinson's disease. Journal of Drug Delivery Science and Technology 66, pages 102793.
Crossref
Crossref
Barbara R. Conway & Muhammad U. Ghori. 2021. Fundamentals of Drug Delivery. Fundamentals of Drug Delivery
393
432
.
Noha M. El Zahar, J. Michael Sutton & Michael G. Bartlett. (2021) Assessment of brain‐to‐blood drug distribution using liquid chromatography. Biomedical Chromatography 35:7.
Crossref
Crossref
Buket Ucar. (2021) Natural biomaterials in brain repair: A focus on collagen. Neurochemistry International 146, pages 105033.
Crossref
Crossref
Ganesh B. Shevalkar, Mahendra K. Prajapati, Rohan V. Pai & Kamlesh D. Mali. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery
249
266
.
Farrukh Zeeshan, Dinesh Kumar Mishra & Prashant Kesharwani. 2021. Theory and Applications of Nonparenteral Nanomedicines. Theory and Applications of Nonparenteral Nanomedicines
153
180
.
Yana Zorkina, Olga Abramova, Valeriya Ushakova, Anna Morozova, Eugene Zubkov, Marat Valikhov, Pavel Melnikov, Alexander Majouga & Vladimir Chekhonin. (2020) Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations. Molecules 25:22, pages 5294.
Crossref
Crossref
Roberta Cassano, Adriana Trapani, Maria Luisa Di Gioia, Delia Mandracchia, Rosalia Pellitteri, Giuseppe Tripodo, Sonia Trombino, Sante Di Gioia & Massimo Conese. (2020) Synthesis and characterization of novel chitosan-dopamine or chitosan-tyrosine conjugates for potential nose-to-brain delivery. International Journal of Pharmaceutics 589, pages 119829.
Crossref
Crossref
Vinay Sridhar, Ankit Tiwari, Sarika Wairkar, Girdhari Lal Gupta & Ram Gaud. (2020) Pramipexole thermosensitive nasal gel for experimental parkinsonism in rats. Journal of Drug Delivery Science and Technology 59, pages 101954.
Crossref
Crossref
Amnon C. Sintov. (2020) AmyloLipid Nanovesicles: A self-assembled lipid-modified starch hybrid system constructed for direct nose-to-brain delivery of curcumin. International Journal of Pharmaceutics 588, pages 119725.
Crossref
Crossref
Namdev Dhas & Tejal Mehta. (2020) Cationic biopolymer functionalized nanoparticles encapsulating lutein to attenuate oxidative stress in effective treatment of Alzheimer’s disease: A non-invasive approach. International Journal of Pharmaceutics 586, pages 119553.
Crossref
Crossref
Lamis H. Salem, Gina S. El-Feky, Rania H. Fahmy, Omaima N. El Gazayerly & Ahmed Abdelbary. (2020) Coated Lipidic Nanoparticles as a New Strategy for Enhancing Nose-to-Brain Delivery of a Hydrophilic Drug Molecule. Journal of Pharmaceutical Sciences 109:7, pages 2237-2251.
Crossref
Crossref
Sita V G & Pradeep Vavia. (2020) Bromocriptine Nanoemulsion-Loaded Transdermal Gel: Optimization Using Factorial Design, In Vitro and In Vivo Evaluation. AAPS PharmSciTech 21:3.
Crossref
Crossref
Subrat K. Bhattamisra, Angeline Tzeyung Shak, Lim Wen Xi, Nurul Hasyanazifa Safian, Hira Choudhury, Wei Meng Lim, Naiyer Shahzad, Nabil A. Alhakamy, Md Khalid Anwer, Ammu K. Radhakrishnan & Shadab Md. (2020) Nose to brain delivery of rotigotine loaded chitosan nanoparticles in human SH-SY5Y neuroblastoma cells and animal model of Parkinson's disease. International Journal of Pharmaceutics 579, pages 119148.
Crossref
Crossref
Vikas Pandey, Anuradha Gadeval, Saket Asati, Priyanka Jain, Navneet Jain, Ram Kumar Roy, Muktika Tekade, Vandana Soni & Rakesh K. Tekade. 2020. Drug Delivery Systems. Drug Delivery Systems
291
332
.
Bharti Gaba, Tahira Khan, Md Faheem Haider, Tausif Alam, Sanjula Baboota, Suhel Parvez & Javed Ali. (2019) Vitamin E Loaded Naringenin Nanoemulsion via Intranasal Delivery for the Management of Oxidative Stress in a 6-OHDA Parkinson’s Disease Model. BioMed Research International 2019, pages 1-20.
Crossref
Crossref
Shuangwen Yu, Xiaolu Xu, Jianfang Feng, Mei Liu & Kaili Hu. (2019) Chitosan and chitosan coating nanoparticles for the treatment of brain disease. International Journal of Pharmaceutics 560, pages 282-293.
Crossref
Crossref
Josef Jampílek, Katarína Kráľová, Petr Novák & Michal Novák. 2019. Nanobiotechnology in Neurodegenerative Diseases. Nanobiotechnology in Neurodegenerative Diseases
65
138
.
Shobhit KumarShweta DangKudeep NigamJaved AliSanjula Baboota. (2018) Selegiline Nanoformulation in Attenuation of Oxidative Stress and Upregulation of Dopamine in the Brain for the Treatment of Parkinson's Disease. Rejuvenation Research 21:5, pages 464-476.
Crossref
Crossref
Franciska Erdő, Luca Anna Bors, Dániel Farkas, Ágnes Bajza & Sveinbjörn Gizurarson. (2018) Evaluation of intranasal delivery route of drug administration for brain targeting. Brain Research Bulletin 143, pages 155-170.
Crossref
Crossref
Yeonoh Shin, Rutika Kokate, Vilas Desai, Alok Bhushan & Gagan Kaushal. (2018) D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels. Drug Discoveries & Therapeutics 12:3, pages 142-153.
Crossref
Crossref
Md. Faheem Haider, Saba Khan, Bharti Gaba, Tausif Alam, Sanjula Baboota, Javed Ali & Asgar Ali. (2018) Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation. Journal of Molecular Liquids 255, pages 384-396.
Crossref
Crossref
Shadab Md, Subrat K. Bhattmisra, Farrukh Zeeshan, Naiyer Shahzad, Md Ali Mujtaba, Venkata Srikanth Meka, Ammu Radhakrishnan, Prashant Kesharwani, Sanjula Baboota & Javed Ali. (2018) Nano-carrier enabled drug delivery systems for nose to brain targeting for the treatment of neurodegenerative disorders. Journal of Drug Delivery Science and Technology 43, pages 295-310.
Crossref
Crossref
Patrícia C. Pires & Adriana O. Santos. (2018) Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies. Journal of Controlled Release 270, pages 89-100.
Crossref
Crossref
M.J. Santander-Ortega, M. Plaza-Oliver, V. Rodríguez-Robledo, L. Castro-Vázquez, N. Villaseca-González, J. González-Fuentes, P. Marcos, M.M. Arroyo-Jiménez & M.V. Lozano. (2017) Colloids for drug delivery to the brain. Journal of Drug Delivery Science and Technology 42, pages 193-206.
Crossref
Crossref
Abdur Rauf Khan, Mengrui Liu, Muhammad Wasim Khan & Guangxi Zhai. (2017) Progress in brain targeting drug delivery system by nasal route. Journal of Controlled Release 268, pages 364-389.
Crossref
Crossref
Shanshan Liu & Paul C Ho. (2017) Intranasal administration of brain-targeted HP-β-CD/chitosan nanoparticles for delivery of scutellarin, a compound with protective effect in cerebral ischaemia. Journal of Pharmacy and Pharmacology 69:11, pages 1495-1501.
Crossref
Crossref
Lijie Huang, Jiangnan Hu, Shengwei Huang, Brian Wang, Felix Siaw-Debrah, Mark Nyanzu, Yu Zhang & Qichuan Zhuge. (2017) Nanomaterial applications for neurological diseases and central nervous system injury. Progress in Neurobiology 157, pages 29-48.
Crossref
Crossref
A. Bonaccorso, T. Musumeci, M.F. Serapide, R. Pellitteri, I.F. Uchegbu & G. Puglisi. (2017) Nose to brain delivery in rats: Effect of surface charge of rhodamine B labeled nanocarriers on brain subregion localization. Colloids and Surfaces B: Biointerfaces 154, pages 297-306.
Crossref
Crossref
Emine Sekerdag. 2017. Nanotechnology Methods for Neurological Diseases and Brain Tumors. Nanotechnology Methods for Neurological Diseases and Brain Tumors
103
113
.
Anam Khan, Syed Sarim Imam, Mohammed Aqil, Abdul Ahad, Yasmin Sultana, Asgar Ali & Khalid Khan. (2016) Brain Targeting of Temozolomide via the Intranasal Route Using Lipid-Based Nanoparticles: Brain Pharmacokinetic and Scintigraphic Analyses. Molecular Pharmaceutics 13:11, pages 3773-3782.
Crossref
Crossref
Gabriel Henrique Hawthorne, Marcelo Picinin Bernuci, Mariza Bortolanza, Vitor Tumas, Ana Carolina Issy & Elaine Del-Bel. (2016) Nanomedicine to Overcome Current Parkinson’s Treatment Liabilities: A Systematic Review. Neurotoxicity Research 30:4, pages 715-729.
Crossref
Crossref
Shobhit Kumar, Javed Ali & Sanjula Baboota. (2016)
Design Expert
®
supported optimization and predictive analysis of selegiline nanoemulsion via the olfactory region with enhanced behavioural performance in Parkinson’s disease
. Nanotechnology 27:43, pages 435101.
Crossref
Crossref
Zachary N. Warnken, Hugh D.C. Smyth, Alan B. Watts, Steve Weitman, John G. Kuhn & Robert O. WilliamsIIIIII. (2016) Formulation and device design to increase nose to brain drug delivery. Journal of Drug Delivery Science and Technology 35, pages 213-222.
Crossref
Crossref
Brijesh Shah, Dignesh Khunt, Manju Misra & Harish Padh. (2016) “Application of Box-Behnken design for optimization and development of quetiapine fumarate loaded chitosan nanoparticles for brain delivery via intranasal route* ”. International Journal of Biological Macromolecules 89, pages 206-218.
Crossref
Crossref
Giovanna Rassu, Elena Soddu, Massimo Cossu, Elisabetta Gavini, Paolo Giunchedi & Alessandro Dalpiaz. (2016) Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review. Journal of Drug Delivery Science and Technology 32, pages 77-87.
Crossref
Crossref
Jia-bao Wei, Qiao Lai, Stepan P. Shumyak, Lan-fang Xu, Chen-xue Zhang, Jia-jun Ling & Yang Yu. (2015) An LC/MS quantitative and microdialysis method for cyclovirobuxine D pharmacokinetics in rat plasma and brain: The pharmacokinetic comparison of three different drug delivery routes. Journal of Chromatography B 1002, pages 185-193.
Crossref
Crossref
Sante Di Gioia, Adriana Trapani, Delia Mandracchia, Elvira De Giglio, Stefania Cometa, Vincenzo Mangini, Fabio Arnesano, Giuliana Belgiovine, Stefano Castellani, Lorenzo Pace, Michele Angelo Lavecchia, Giuseppe Trapani, Massimo Conese, Giovanni Puglisi & Tommaso Cassano. (2015) Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics 94, pages 180-193.
Crossref
Crossref
Dongli Fan, ShuangShuang Wu, Shu Tian, Jingyang Zhou, Yun Ju, Chunjuan Ma & Jian Shi. (2014) Detection of dopamine on a poly(metanilic acid) decorated two-dimensional gold cavity array electrode. RSC Adv. 4:91, pages 49560-49568.
Crossref
Crossref